Background
Introduction
Cardiovascular disease (CVD) is a leading cause of mortality worldwide. In 2015, it accounted for 17.9 million deaths, or almost one third of all deaths globally. 1 New strategies to prevent CVD are highly sought after from both a humanitarian and economical perspective. The identification of causal risk factors associated with CVD is expected to provide important insights on how to develop new strategies.
Over the past decades, several kidney-related biomarkers have been proposed to be associated with CVD, 2,3 but their potential causal role in disease processes is incompletely understood. We used urinary biomarkers, as proxies for kidney function, to try to shed light on this relationship and to pinpoint causal risk biomarkers involved in this association.
The association of high sodium and low potassium intake with elevated blood pressure is supported by a large body of evidence that includes randomized clinical trials, 4, 5 as well as observational cohort studies. 6, 7 The Trials of Hypertension Prevention (TOPH), conducted in 1987-1990 and 1990-1995 , respectively, showed that reducing dietary sodium in individuals with prehypertension decreased the risk of cardiovascular events and overall mortality up to 20 years after the original trial. [8] [9] [10] For CVD, two previous meta-analyses of prospective cohort studies detected significant positive relationships between sodium intake and stroke, as well as CVD outcomes. 11, 12 Similarly, in observational epidemiologic studies, high albuminuria is associated with risk for cardiovascular events in individuals with or without diabetes mellitus.
13,14
One recent Mendelian randomization (MR) study 15 supported the existence of a bidirectional causal association between albuminuria and blood pressure, implying that albuminuria could increase risk of cardiovascular disease through blood pressure. There is a lack of prior studies comprehensively examining several urinary biomarkers reflecting different aspects of kidney function and their associations with blood pressure, type 2 diabetes (T2D) and CVD in a large study sample from the general population. Furthermore, the causal associations of these biomarkers with cardiometabolic traits are incompletely understood.
The aims of this study were to first determine the associations between urinary biomarkers, specifically urinary sodium, potassium and albumin, with cardiovascular risk factors, T2D and CVD in the UK Biobank by means of observational analyses including sex-stratified analyses; and then to test whether any of these associations are causal using a two-sample MR approach, combining UK Biobank data with publicly available data from relevant genome-wide association studies (GWAS).
Methods

Study Population
The UK Biobank is a longitudinal cohort study of >500 000 individuals aged 40 to 69 years initiated in the United Kingdom in 2006-2010. 16 We used the data collected at the UK Biobank assessment centers at baseline, combined with information on incident events from the hospital and death registries. 
Definition of Exposure and Cardiovascular Outcomes for Observational Analyses
The exposures of interest for our main analysis were urinary sodium (field ID 30530) to potassium (field ID 30520) excretion ratio (UNa/UK), and urinary albumin (field ID 30500) to creatinine (field ID 30510) ratio (UAlb/UCr). We analyzed urinary sodium to creatinine ratio (UNa/UCr) and urinary potassium to creatinine ratio (UK/UCr) for secondary analyses. The method of using spot-urine samples to approximate 24-hour excretion is widely used, as a convenient alternative in assessing population mean sodium and potassium intake, especially for surveys with large populations. 17, 18 Cardiovascular outcomes were defined using the inpatient hospital and death 
Definition of Confounders for Observational Analyses
We used data from questionnaires to derive the following potential confounders: sex (ID 
Statistical Methods
Observational Analysis
After examining distributions of all variables, we applied rank-based inverse normal transformation for the urinary biomarkers, and for all the continuous variables included in the study. Linear/logistic and Cox regressions analyses were conducted with the R software and R package Survival (version 3.3.0), respectively.
Mendelian Randomization
We performed two-sample MR analyses using data from publicly available consortia, except for blood pressure where we performed a GWAS in UK Biobank (as the publicly available GWAS summary statistics were adjusted for BMI). We used the results of previous GWAS of UNa/UK, UNa/UCr, UK/UCr and UAlb/UCr performed by our group 19 available at GRASP resource (https://grasp.nhlbi.nih.gov/FullResults.aspx), as instrument variables (IVs). A list of the variants included in the IV is shown in eTable 1.
We assessed the causal relationships of the four urinary biomarkers with risk factors for CVD (SBP, DBP, BMI, WHR). We did not study causal associations of UNa/UK, UNa/Cr and UK/Cr with any hard CVD endpoints due to lack of statistical power (eTable 2). We assessed the causal relationships of UAlb/UCr with AF and T2D (power estimates >75%) (eTable 2).
We performed two-sample MR using three separate methods to estimate causal effects: the standard inverse-variance weighted (IVW) regression; as well as two robust regression methods, the weighted median-based method, and Egger regression. 20 We performed leave-one-out sensitivity analyses to identify if a single SNP was driving an association. In addition, we performed bidirectional MR and multivariable MR for significant causal outcomes.
We performed the two-sample MR analyses, 20, 21 as well as the bidirectional MR and the multivariable MR with the R package, TwoSampleMR. In addition, we used the MR-PRESSO software 22 to minimize the risk of horizontal pleiotropy affecting our results. Details of the GWAS summary statistics used to performed MR analyses and variance explained by our instruments can be found in eTable 2.
We estimated statistical power for each of the MR analyses using variance explained from our exposures and effect size from observational analyses and an alpha threshold of 0.05. In addition, we calculated the statistical power using a fixed effect of and was driven by the adjustment for creatinine. Indeed, urine sodium, potassium and albumin not adjusted for creatinine showed significant positive associations with obesity traits (eTable 4).
In our sensitivity analyses, after excluding participants using diuretics, ACE When participants eligible for inclusion in the main analysis were stratified by sex (eTable 5 and eFigure 4), no additional significant associations were found between exposures and outcomes in either subset. All associations between urinary biomarkers and outcomes remained significant and consistent with the main analyses in both men and women. Events were more common in the male sample set for all CVD outcomes (eTable 5). Generally, males displayed larger effect estimates than females. For disease outcomes, this potentially could be explained by better statistical power (more events), while the power should be equal for continuous traits (as the number of measurements were similar). The strongest sex interactions were observed for UAlb/UCr and T2D (P<2E10-16), and across urinary biomarkers and obesity traits (P<2E-16) (eTable 5 and eFigure 4).
After correcting for horizontal pleiotropy, we found evidence of causal associations between UNa/UK and BMI, UAlb/UCr and T2D, and of both biomarkers (UNa/UK and UAlb/UCr) with blood pressure and WHR (Table 2 and Figure 1) . A leave-one out sensitivity analysis did not highlight any SNPs with a large effect on the results. After excluding heterogeneous SNPs using MR-PRESSO (eFigures 5-8), our analysis showed no significant heterogeneity and no significant directional horizontal pleiotropy.
Numbers of variants included in the analyses, number of outliers excluded, and full results are shown in eTable 6. We only performed MR analyses for outcomes for which we had at least 75% statistical power (eTable 2).
We found evidence of causal bidirectional effect across UNa/UK and UAlb/UCr and blood pressure, and between albumin and T2D (eTable 7).
We performed multivariable MR using all established GWAS significant variants for UAlb/UCr, SBP and WHR as predictor variables, and GWAS of T2D and AF as outcome variables. We detected an independent association between UAlb/UCr and T2D, while the association of UAlb/UCr with AF was mediated by SBP (eTable 8).
Discussion
Principal Findings
We studied associations of urinary biomarkers with cardiometabolic disease in 478,311 individuals free of chronic kidney disease and CVD at baseline. We made four main findings. First, we found a positive association between UNa/UK and albumin with blood pressure, as well as with adiposity-related measures (body fat percentage, BMI, or WHR). Second, we observed a direct association of UAlb/UCr with CVD incidence, but an inverse association of UNa/UK with incident CVD and T2D in traditional observational analyses. Third, the strongest sex differences were observed for associations between UAlb/UCr and T2D, and across urinary biomarkers and obesity traits. However, all associations were directionally consistent. Lastly, using a Mendelian randomization approach, we provide evidence that higher UNa/UK is causally related with higher blood pressure, and we highlight a feed-back causal loop between albumin and hypertension, and between albumin and T2D.
Comparison with Prior Observational Studies
Our results are consistent with previous literature which reported that high albumin is associated with higher susceptibility to CVD 13 and hypertension. 15 Previous studies have shown inconsistent results between sodium intake and the risk of CVD. The Scottish Heart Study, a population-based longitudinal study of 10,000 people, showed no consistent associations between sodium intake and cardiovascular or all-cause mortality. 23 On the other hand, previous meta-analyses of observational studies have suggested a direct association of sodium intake with stroke and CAD events, 12 and a potential inverse association between potassium intake and risk of stroke and other CVD outcomes. 24 In agreement with these findings, randomized interventional trials have shown that sodium reduction can reduce the long term risk of developing high blood pressure, 25 cardiovascular events 8, 9 and death. 10 Our findings from observational analyses show an inverse relationship between UNa/UK excretion and AF, CAD, and IS. A study recently published in the Lancet found a positive association between sodium intake and stroke only in communities where mean intake was greater than 5 g/day, largely confined to China. By contrast, they found an inverse relation with myocardial infarction and mortality. The same study also showed that the rates of stroke, cardiovascular death, and total mortality decreased with increasing potassium intake across all the communities studied. 26 We detected an inverse association between UNa/UK and hyperlipidemia in line with a previous meta-analysis of randomized controlled trials which found that a low sodium diet intervention was associated with an increase in cholesterol and triglycerides. 27 We also identified an inverse association between UNa/UK and T2D in the UK Biobank cohort. To the best of our knowledge, the relationship between sodium intake and incidence of T2D has not been previously described. In contrast, the association between albumin and diabetes was already observed in previous studies 28 ,
and it is consistent with the positive association detected by our study.
We also confirmed the well-established direct association between sodium intake and blood pressure, as well as the inverse association between potassium intake and blood pressure [4] [5] [6] [7] in the UK Biobank cohort. In addition, we replicated these associations using urinary sodium and urinary potassium adjusted for creatinine.
Regarding albumin and blood pressure, our results are consistent with a recent previous study 15 which supported the existence of a bidirectional causal association between albuminuria and blood pressure.
We observed positive associations between UNa/UK and albumin with obesity and adiposity-related risk factors (body fat percentage, BMI, WHR). These results are consistent with previous studies that have suggested that sodium intake is an independent risk factor for obesity, 29, 30 and that albuminuria is one the most important risk factors for obesity 31 .
No previous MR studies have investigated the causality of UNa/UK with cardiovascular outcomes and risk factors, and of albumin with T2D. Our MR results mirror and extend findings from previous randomized interventional trials 4, 5 that have established sodium intake as a risk factor for hypertension. In addition, we highlight a feed-back causal loop between albumin and T2D, and we also replicate the existence of a bidirectional causal association between albuminuria and blood pressure that was reported by a recent MR study. 15 The Potential Causal Role of Urinary Biomarkers in Blood Pressure and Type 2
Diabetes Mellitus
The incidence and prevalence of hypertension continue to rise, presumably due to an aging population, increasing obesity and physical inactivity. 32 Substantial evidence from clinical trials have demonstrated that high sodium and low potassium intake are significantly associated with elevated blood pressure. 4, 5 Previous studies also show that reducing dietary sodium in individuals with prehypertension decrease the risk of cardiovascular events and overall mortality. [8] [9] [10] This is the first study exploring this association using genetic data by means of a MR approach. We confirm a causal role of high sodium and low potassium excretion -arguably reflecting dietary intake -in higher susceptibility for increased blood pressure. A high-sodium diet suppresses the reninangiotensin-aldosterone system. Endothelial dysfunction probably plays an important role to modulate the influence of high sodium intake on blood pressure, although the exact mechanisms remain elusive. 33 We also observed a bidirectional causal association of albumin with blood pressure. The causal association of albumin with blood pressure was already highlighted in a recent study that suggested the existence of a feed-forward loop where elevated blood pressure leads to increased albuminuria, which in turn further increases blood pressure. 15 The presence of albuminuria is a powerful predictor of renal and cardiovascular risk in patients with T2D and hypertension. Multiple studies have shown that decreasing albuminuria reduces the risk of adverse renal and cardiovascular outcomes. The pathophysiology is not definitively known, but also in this case, it is hypothesized to be related to endothelial dysfunction, inflammation, and/or abnormalities in the renin-angiotensin-aldosterone system. 34 Glomerular endothelial dysfunction is also implicated in the link between albuminuria and T2D. 35, 36 Our data suggest an independent causal association between T2D and albumin, not mediated by blood pressure. Urine albumin arises primarily from the increased passage of albumin through the glomerular filtration barrier that is insufficiently reabsorbed by tubular epithelium. The filtration barrier is comprised of the endothelium, glomerular basement membrane, and podocytes. T2D can lead to disruption of each of these components including the endothelium in which disruption of the endothelial glycocalyx through dysregulation by the diabetic milieu. 35 Indeed, diabetic patients have decreased systemic glycocalyx volume, and this is correlated with the presence of albuminuria. 37 
Strengths and Limitations
Our study is the largest and most comprehensive study of associations of urinary biomarkers with cardiovascular risk factors, T2D and CVD to date. Strengths of our study include the large sample size, the robustness of our findings, the most recent and powerful GWAS summary statistics as outcomes, and a new method, the MR-PRESSO, to decrease the risk of pleiotropy.
Our study also has several limitations. First, we are limited to using measures currently available in the UK Biobank. We excluded participants with diagnoses indicating kidney disease, but using an estimated glomerular filtration rate would have been a more accurate method to exclude individuals with mild CKD. Such an exclusion cannot be performed until serum creatinine measurements are available in the UK Biobank in the future. Second, the vast majority of participants were of European ancestry despite the inclusion of several non-European ethnicities. Hence, our results may not be generalizable to other race/ethnic groups with significantly different diets and/or prevalence and predispositions to cardiometabolic disease. Finally, statistical power to detect potentially causal relationships through our MR studies was limited for some traits, at least for smaller effects, including some of those observed in our traditional epidemiological analyses.
Conclusions
Our study mirrors and extends findings from randomized interventional trials which have established sodium intake as a risk factor for hypertension. In addition, we detect a feed-back causal loop between albumin and hypertension, and our finding of a bidirectional causal association between albumin and T2D reflects the well-known nephropathy in T2D. 
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